ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 350,37
-1,05%
Dow Jones
41 763,46
-0,90%
DAX
19 077,54
-0,98%
Brent Oil
73,945
-0,09%
Bitcoin
70 096,13
-0,16%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. GRI Bio Inc (GRI)

  7. GRI Bio Inc (GRI) Actualités

GRI

GRI Bio (GRI)

GRI Bio Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:GRI
DateHeureSourceTitreSymboleSociété
25/10/202423h18Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:GRIGRI Bio Inc
24/10/202414h35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRIGRI Bio Inc
24/10/202414h30GlobeNewswire Inc.GRI Bio Raises a Total of $13.9 Million in Gross Proceeds Since the Beginning of 2024NASDAQ:GRIGRI Bio Inc
21/10/202423h35GlobeNewswire Inc.GRI Bio Announces Exercise of WarrantsNASDAQ:GRIGRI Bio Inc
16/10/202414h45GlobeNewswire Inc.GRI Bio Presents Positive Preclinical Data Demonstrating GRI-0621’s Ability to Inhibit Invariant Natural Killer T (iNKT) Cell Activity and Reduce Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)NASDAQ:GRIGRI Bio Inc
07/10/202414h30GlobeNewswire Inc.GRI Bio to Present at the 22nd International Colloquium on Lung and Airway FibrosisNASDAQ:GRIGRI Bio Inc
30/09/202414h30GlobeNewswire Inc.GRI Bio Granted Japan Patent for Proprietary Natural Killer T (NKT) Cell Modulators for Prevention and Treatment of Inflammatory ConditionsNASDAQ:GRIGRI Bio Inc
26/09/202414h00GlobeNewswire Inc.GRI Bio Receives Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in AustraliaNASDAQ:GRIGRI Bio Inc
25/09/202414h45GlobeNewswire Inc.GRI Bio (NASDAQ: GRI) to Participate in a Virtual Investor CEO Connect SegmentNASDAQ:GRIGRI Bio Inc
18/09/202415h00GlobeNewswire Inc.GRI Bio Participates in Virtual Investor KOL Connect SegmentNASDAQ:GRIGRI Bio Inc
05/09/202414h45GlobeNewswire Inc.GRI Bio to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:GRIGRI Bio Inc
04/09/202414h45GlobeNewswire Inc.GRI Bio to Present at the 2024 European Respiratory CongressNASDAQ:GRIGRI Bio Inc
14/08/202414h05GlobeNewswire Inc.GRI Bio Reports Second Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:GRIGRI Bio Inc
15/07/202415h05GlobeNewswire Inc.GRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Lunch Break SeriesNASDAQ:GRIGRI Bio Inc
11/07/202415h20GlobeNewswire Inc.GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” SegmentNASDAQ:GRIGRI Bio Inc
08/07/202415h05GlobeNewswire Inc.GRI Bio Regains Compliance with NasdaqNASDAQ:GRIGRI Bio Inc
02/07/202415h05GlobeNewswire Inc.GRI Bio Announces Publication of Positive Preclinical Data from Lead Program GRI-0621 in the American Journal of Respiratory and Critical Care MedicineNASDAQ:GRIGRI Bio Inc
01/07/202414h45GlobeNewswire Inc.GRI Bio to Present at the 8th Annual IPF SummitNASDAQ:GRIGRI Bio Inc
28/06/202422h05GlobeNewswire Inc.GRI Bio Announces Closing of $4.0 Million Public OfferingNASDAQ:GRIGRI Bio Inc
27/06/202415h00GlobeNewswire Inc.GRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell ModulatorsNASDAQ:GRIGRI Bio Inc
27/06/202414h00GlobeNewswire Inc.GRI Bio Announces Pricing of $4 Million Public OfferingNASDAQ:GRIGRI Bio Inc
14/06/202414h05GlobeNewswire Inc.GRI Bio Announces Reverse Stock SplitNASDAQ:GRIGRI Bio Inc
11/06/202415h00GlobeNewswire Inc.GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor Pitch ConferenceNASDAQ:GRIGRI Bio Inc
22/05/202415h15GlobeNewswire Inc.GRI Bio (NASDAQ: GRI) Participates in Virtual Investor “What This Means” Segment Highlighting Positive Preclinical Data from Idiopathic Pulmonary Fibrosis (IPF) and Systemic Lupus Erythematosus (SLE) ProgramsNASDAQ:GRIGRI Bio Inc
21/05/202414h35GlobeNewswire Inc.GRI Bio Presents Positive Preclinical Data from Pipeline of NKT Cell Modulators in Development for the Treatment of Systemic Lupus Erythematosus (SLE)NASDAQ:GRIGRI Bio Inc
20/05/202414h45GlobeNewswire Inc.GRI Bio Presents Positive Preclinical Data Demonstrating Lead Program GRI-0621 Reduces the Important Inflammatory and Fibrotic Drivers in Idiopathic Pulmonary Fibrosis (IPF)NASDAQ:GRIGRI Bio Inc
14/05/202415h05GlobeNewswire Inc.GRI Bio to Present at Alliance Global Partner’s 2024 Healthcare Company ShowcaseNASDAQ:GRIGRI Bio Inc
13/05/202414h00GlobeNewswire Inc.GRI Bio Reports First Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:GRIGRI Bio Inc
29/04/202414h45GlobeNewswire Inc.GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on AutoimmunityNASDAQ:GRIGRI Bio Inc
25/04/202415h15GlobeNewswire Inc.GRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment WebinarNASDAQ:GRIGRI Bio Inc
 Showing the most relevant articles for your search:NASDAQ:GRI

Dernières Valeurs Consultées

ASX
MGGBOA
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés